Store
At-Home Diagnostic Testing Markets and Trends, 2022
Publication Date: March 29, 2022
Tags: Coagulation, COVID-19, Diagnostic Instruments, In Vitro Diagnostics (IVD), Infectious Disease Testing Instruments, Point-of-Care (POC) Testing
Pages: 40
SKU: 22-045
The At-Home Diagnostic Testing Markets and Trends (COVID-19, FOB, Glucose, HIV, and Other Tests) report provides an in-depth analysis of the rapidly growing at-home IVD testing market. This report focuses exclusively on tests where the entire process—from sample collection to results—occurs at home, delivering results within one hour. It excludes tests that require samples to be sent to a laboratory for analysis.
The report provides insights into demographic trends, new developments, innovative technology, and global expansion that drive the forecast from 2021 to 2026. It highlights the significant potential and growth opportunities in the at-home IVD testing market, driven by the increasing demand for convenient, rapid diagnostic solutions.
Market Segmentation:
The report is segmented into three main areas:
- Glucose Testing
- Infectious Disease Testing
- Other Testing Areas
Market Data:
All market data pertains to the global market at the manufacturers’ level. The report includes:
- Base Year Data: 2021
- Forecast Data: 2021 and 2026
- Compound Annual Growth Rates (CAGRs): For 2021 and 2026
- Competitive Analysis: Focused on the top five market participants
- Regional Breakdown: United States, EMEA (Europe, the Middle East, and Africa), Asia-Pacific, and Rest of the World
Competitive Landscape:
The report profiles major companies in the market, offering a competitive analysis of top participants, their market shares, and strategies.
Table: Estimated Global At-Home IVD Infectious Disease Testing Market, 2021-2026 (in millions $)
| Segment | 2021 Mkt $ | 2026 Mkt $ | CAGR % |
| At-Home Infectious Disease Testing | $XX Million | $XX Million | XX% |
| Market Distribution by Segment: | |||
| COVID-19 | XX% | XX% | XX% |
| Other Infectious Disease | XX% | XX% | XX% |
Source: Kalorama Information
For further details and to purchase directly, please contact us.
Table of Contents
Chapter 1. Executive Summary
Industry at a Glance
Scope and Methodology
Size and Growth of the Market
- Figure 1-1: Global At-Home IVD Market by Key Segment (Glucose, COVID-19, Other), 2019-2021
Key Issues and Trends Affecting the Market
Competitive Outlook
Conclusion Highlights
Chapter 2: Introduction
Overview
At-Home Tests by Test Type
- Table 2-1: Global At-Home IVD Market by Test Type, 2021 ($BN)
- Figure 2-1: Global At-Home IVD Market by Distribution of Sales by Segment (Glucose, COVID-19, HIV, Other Infections, Cholesterol, Drug of Abuse, Coagulation, FOB, Pregnancy & Fertility, Other), 2021
At-Home Tests by Sample Type
- Table 2-2: Global At-Home IVD Market by Sample Type, 2021 ($BN)
- Figure 2-2: Global At-Home IVD Market by Distribution of Sales by Sample Type (Blood, Urine, Oral/Saliva, Nasal, Stool, Other), 2019 and 2021
Blood Samples
- Figure 2-3: Estimated Distribution of Blood Sample Sales by Test Type, 2021
Urine Samples
- Figure 2-4: Estimated Distribution of Urine Sample Sales by Test Type, 2021
Oral/Saliva Samples
- Figure 2-5: Estimated Distribution of Oral/Saliva Sample Sales by Test Type, 2021
Nasal Samples
- Figure 2-6: Estimated Distribution of Nasal Sample Sales by Test Type, 2021
Stool Samples
- Figure 2-7: Estimated Distribution of Stool Sample Sales by Test Type, 2021
Other
Chapter 3: Issues and Trends
COVID-19
At-Home COVID-19 Test Distribution of Sales by Vendor
Insurance for At-Home Tests
Diabetes State Mandates – State-Level Insurance Mandates for Benefits, ACA Marketplace Coverage
At-Home IVD Testing Drivers and Challenges
Chapter 4: Market Participants
Abbott
- Table 4-1: Corporate Summary
Company Overview
Acon Laboratories, Inc.
- Table 4-2: Acon Laboratories Corporate Summary
Company Overview
Ascensia Diabetes Care Holdings AG
- Table 4-3: Ascensia Diabetes Care Corporate Summary
Company Overview
Becton-Dickinson
- Table 4-4: Becton-Dickinson Corporate Summary
Company Overview
Dexcom, Inc.
- Table 4-5: Dexcom Corporation Corporate Summary
Company Overview
OraSure Technologies, Inc.
- Table 4-6: OraSure Technologies Summary
Company Overview
Quidel Corporation
- Table 4-7: Quidel Corporate Summary
Company Overview
Roche Diagnostic Corporation
- Table 4-8: Roche Diagnostic Corporate Summary
Company Overview
Siemens Healthineers GmbH
- Table 4-9: Siemens Healthineers Corporate Summary
Company Overview
Swiss Precision Diagnostics GmbH
- Table 4-10: Swiss Precision Diagnostics Corporate Summary
Company Overview
Chapter 5: Market Analysis
- Market Overview
- Figure 5-1: Global At-Home IVD Market, 2021-2026, 8% CAGR, (S MN)
- Figure 5-2: Year-over-Year Growth (’19-20, ’20-21) for At-Home IVD Markets, %
Market Segment by Test Type
- Figure 5-3: Global At-Home IVD Market by Test Type, 2019-2021 ($MN)
- Figure 5-4: Global At-Home IVD Market by General Test Segment, 2021
Glucose
- Table 5-1: Estimated Global At-Home IVD Glucose Testing Market, 2021-2026 $MN; CAGR 21-26
Infectious Disease
- Table 5-2: Estimated Global At-Home IVD Infectious Disease Testing Market, 2021-2026 $MN; CAGR 21-26
Other Areas
- Table 5-3: Estimated Global At-Home IVD Other (Cholesterol, Coagulation, Drug of Abuse, Fecal Occult Blood, Pregnancy/Fertility, Other) Testing Market, 2021-2026 $MN; CAGR 21-26
Market by Region
- Figure 5-5: Estimated Global At-Home IVD Testing Market by Region, 2019-2021
Competitive Analysis
Top Five Market Leaders
- Figure 5-6: Estimated Global At-Home IVD Testing Market, Vendor Market Share 2021
Related products
Remote Patient Monitoring and Telehealth Markets, 13th Edition
November 27, 2023
Telehealth and remote patient monitoring have revolutionized healthcare by improving health conditions and preventing complications. The pandemic accelerated the adoption of telemedicine, boosting confidence in virtual patient assessments and technological monitoring. Remote Patient Monitoring and Telehealth Markets, 13th Edition by Kalorama Information explores these transformations and more, providing a comprehensive analysis of the market.
…
$5,000.00 – $7,500.00
The Worldwide Market for Clinical Laboratory Services, 9th Edition
June 25, 2024
Understanding the clinical laboratory market is crucial for effective business planning. The Worldwide Market for Clinical Laboratory Services, 9th Edition answers essential questions such as the size of the service market for clinical testing, the types of tests that are in demand, and the future trajectory of this market 2023-2028. It also identifies the companies…
$5,000.00 – $7,500.00
Cell Therapy and Gene Therapy Disease Markets, 2023-2029
April 30, 2024
Explore the future of medicine with our in-depth report on cell therapy, gene therapy, and RNA therapy markets. Cell therapy and gene therapy represent a frontier in modern medicine, promising revolutionary treatments by treating the underlying genetic causes of disease and by genetically controlling the body’s immune system. Recent years have seen an increase in…
$5,000.00 – $7,875.00
